Sodium zirconium cyclosilicate for treating hyperkalaemia (TA599)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 4 September 2019
Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132)Product type:GuidanceProgramme:NICE guidelinePublished date: 23 May 2019
Patiromer for treating hyperkalaemia [ID877]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 5 February 2020
Avatrombopag and lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing an elective procedure [ID1520]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 26 February 2020
Andexanet alfa for reversing anticoagulation [ID1101]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 10 June 2020
Zynteglo for treating transfusion-dependent beta-thalassaemia ID968Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 24 June 2020
Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly ID1596Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 2 December 2020
Management of goutStatus:In developmentProgramme:NICE guidelineExpected publication date: 4 April 2022
Caplacizumab for treating adults experiencing an episode of acquired thrombotic thrombocytopenic purpura [ID1185]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Emapalumab for treating primary haemophagocytic lymphohistiocytosis (ID1438)Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
Fostamatinib for treating persistent or chronic immune thrombocytopenia [ID1087]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
L-glutamine for preventing painful crises in sickle cell disease in people aged 5 years and over [ID1523]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Midostaurin for treating advanced systemic mastocytosis ID1573Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
Voxelotor for treating sickle cell disease [ID1403]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
Luspatercept for treating beta-thalassaemia ID1554Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC
Luspatercept for treating anaemia caused by myelodysplastic syndromes [ID1550]Status:ProposedProgramme:Technology appraisal guidanceExpected publication date: TBC